Recurrent Talaromyces Marneffei Infection Revealing X-Linked Hyper IgM Syndrome in an HIV-Negative Infant: A Diagnostic and Therapeutic Challenge
- PMID: 41451037
- PMCID: PMC12728417
- DOI: 10.2147/IDR.S557554
Recurrent Talaromyces Marneffei Infection Revealing X-Linked Hyper IgM Syndrome in an HIV-Negative Infant: A Diagnostic and Therapeutic Challenge
Abstract
Talaromyces marneffei (TM), a temperature-dependent dimorphic fungus and opportunistic pathogen, poses a significant threat to immunocompromised individuals, particularly in Southeast Asian regions such as China and India. This case report details an 8-month-old HIV negative Chinese infant with recurrent cough and fever, who was diagnosed with TM infection through blood culture and metagenomic next-generation sequencing (mNGS). Additionally, whole exome sequencing identified a point mutation (c.346+1G>T) in the child's CD40LG gene, primary immunodeficiency calized to chromosome position chrX:135736590, leading to X-linked Hyper IgM Syndrome (XHIGM). The patient was managed with intravenous immunoglobulin (IVIG) and a 12-day course of amphotericin B and itraconazole, which led to significant clinical improvement and discharge on a quarterly IVIG regimen. However, he required readmission for recurrent TM pneumonia at 9 and 40 months post-discharge. This case highlights the diagnostic challenge and management complexity of TM infection in the context of primary immunodeficiency.
Keywords: Talaromyces marneffei; X-linked hyper IgM syndrome; immunocompromised individuals; mNGS; primary immunodeficiency.
© 2025 Li et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
-
- Dunn CP, de la Morena MT. X-Linked Hyper IgM Syndrome. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews Is a Registered Trademark of the University of Washington, Seattle. University of Washington; 1993.
-
- Thompson Iii GR, Le T, Chindamporn A, et al. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology. Lancet Infect Dis. 2021;21(12):e364–e374. doi: 10.1016/s1473-3099(21)00191-2 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
